Adipose tissue-derived mesenchymal stem cells in long-term dialysis patients display downregulation of PCAF expression and poor angiogenesis activation

• Published in: PloS one Vol. 9; no. 7; p. e102311
• Main Authors: Yamanaka, Shuichiro, Yokote, Shinya, Yamada, Akifumi, Katsuoka, Yuichi, Izuhara, Luna, Shimada, Yohta, Omura, Nobuo, Okano, Hirotaka James, Ohki, Takao, Yokoo, Takashi
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 15.07.2014; Public Library of Science (PLoS)
• Subjects: Activation; Adipocytes; Adipose tissue; Adipose Tissue - cytology; Adult; Angiogenesis; Biocompatibility; Biology and Life Sciences; Biomedical materials; Body fat; Bone marrow; Case-Control Studies; Chondrocytes; Chondrogenesis; Chronic kidney failure; Dialysis; Differentiation; Down-Regulation; End-stage renal disease; Epigenetics; Erythropoietin; Event-related potentials; Female; Gene expression; Hemodialysis; Histone acetyltransferase; Humans; Hypertension; Hypoxia; Hypoxia-inducible factors; Internal medicine; Kidney diseases; Kidneys; Male; Medicine; Medicine and Health Sciences; Mesenchymal stem cells; Mesenchymal Stem Cells - cytology; Mesenchyme; Middle Aged; Neovascularization, Pathologic; Nephrology; Osteoblastogenesis; Osteoblasts; p300-CBP Transcription Factors - metabolism; Patients; PCAF protein; Proteomics; Regeneration; Renal Dialysis; Rodents; Senescence; Stem cells; Tissues; Transcription factors; Uremia; Urine; Vascular endothelial growth factor; Viability; Japan
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0102311

We previously demonstrated that mesenchymal stem cells (MSCs) differentiate into functional kidney cells capable of urine and erythropoietin production, indicating that they may be used for kidney regeneration. However, the viability of MSCs from dialysis patients may be affected under uremic conditions. In this study, we isolated MSCs from the adipose tissues of end-stage kidney disease (ESKD) patients undergoing long-term dialysis (KD-MSCs; mean: 72.3 months) and from healthy controls (HC-MSCs) to compare their viability. KD-MSCs and HC-MSCs were assessed for their proliferation potential, senescence, and differentiation capacities into adipocytes, osteoblasts, and chondrocytes. Gene expression of stem cell-specific transcription factors was analyzed by PCR array and confirmed by western blot analysis at the protein level. No significant differences of proliferation potential, senescence, or differentiation capacity were observed between KD-MSCs and HC-MSCs. However, gene and protein expression of p300/CBP-associated factor (PCAF) was significantly suppressed in KD-MSCs. Because PCAF is a histone acetyltransferase that mediates regulation of hypoxia-inducible factor-1α (HIF-1α), we examined the hypoxic response in MSCs. HC-MSCs but not KD-MSCs showed upregulation of PCAF protein expression under hypoxia. Similarly, HIF-1α and vascular endothelial growth factor (VEGF) expression did not increase under hypoxia in KD-MSCs but did so in HC-MSCs. Additionally, a directed in vivo angiogenesis assay revealed a decrease in angiogenesis activation of KD-MSCs. In conclusion, long-term uremia leads to persistent and systematic downregulation of PCAF gene and protein expression and poor angiogenesis activation of MSCs from patients with ESKD. Furthermore, PCAF, HIF-1α, and VEGF expression were not upregulated by hypoxic stimulation of KD-MSCs. These results suggest that the hypoxic response may be blunted in MSCs from ESKD patients.